<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Unlocking Opportunities: Navigating a Tax-Free Sale for Lam Research Employees

image-table

Healthcare Provider Update: Healthcare Provider for Lam Research Lam Research offers healthcare benefits through a variety of providers. While specific details about the exact healthcare insurer may vary based on employee health plan selections, employees typically can choose from major insurance networks, including providers like Anthem and Kaiser Permanente, as per the company's offerings. Potential Healthcare Cost Increases in 2026 In 2026, healthcare costs are forecasted to see significant increases, driven by a confluence of factors. Individuals enrolled in the Affordable Care Act (ACA) marketplace could be particularly affected, with potential premium hikes exceeding 60% in some states. The anticipated expiration of enhanced federal subsidies could leave nearly 92% of policyholders facing steep out-of-pocket expenses, with some projections indicating increases upwards of 75%. Coupled with ongoing medical cost inflation and surging drug prices, these dynamics pose challenges for employees at organizations like Lam Research as they navigate their healthcare options in a rapidly changing landscape. Click here to learn more

What Is a Tax-Free Sale?

You want to sell the business that you have owned for years. It has appreciated significantly in value, but you want to retire or move on to something else. If you simply sell the business for cash, you will realize a significant taxable gain. However, if you want to avoid paying capital gains tax now, you can opt for what is known as a tax-free sale or tax-free reorganization of your business. Under certain conditions, as set forth in Section 368 (a) (1) of the Internal Revenue Code, you can structure a tax-free sale of your business. In such a transaction, you exchange your business's stock or assets tax-free for the voting stock of an acquiring corporation.

Technical Note:  A variation on the tax-free sale is the statutory merger, whereby two or more corporations merge under state corporate law to form a single corporation, and one of the original corporations ceases to exist. Such a merger may also qualify as a tax-free transaction under Section 368 (a) (1) of the Internal Revenue Code. In many cases, the seller in a tax-free sale is a small or closely held business, while the buyer is a large, publicly held corporation. Structuring a tax-free sale may make sense if you own a viable small business and want to sell it without immediate tax consequences. However, because this kind of transaction must meet complex IRS rules and requirements, you should consult additional resources including your tax advisor and/or attorney. There are three basic types of tax-free sales:

Tax-Free Stock Sale

Tax-free stock sales, known as 'B' reorganizations, occur when the selling corporation trades its shares of stock for voting stock in the purchasing corporation. Although you don't have to exchange all shares of your company's stock, the Internal Revenue Code requires that you sell at least 80 percent of your corporation's shares of voting stock and at least 80 percent of the total number of shares of other classes of stock. In exchange, you must receive only shares of voting stock from the acquiring corporation. If you receive shares of any other class of stock, the transaction will not be eligible for tax-free status.

Tax-Free Asset Sale

Tax-free asset sales, known as 'C' reorganizations, occur when the selling corporation exchanges its assets or properties for voting stock in the acquiring corporation. For this type of transaction, the IRS requires the sale of substantially all of the selling corporation's assets to the acquiring corporation. Although the IRS does not explicitly state how much of the selling corporation's assets should be sold, you should retain only those assets needed to meet your business's pre-existing liabilities.

Generally, a 'C' reorganization will satisfy IRS regulations if your business transfers assets to the acquiring corporation with a value equal to at least 90 percent of the fair market value (FMV) of net assets (gross assets less liabilities) and at least 70 percent of the FMV of the gross assets. After a tax-free asset sale, the selling corporation must be liquidated, if you and the other shareholders of the selling corporation desire to hold the stock of the acquiring corporation directly.

An asset sale may still qualify for tax-free treatment if some of the shares of stock of the acquiring corporation are not voting shares. However, at least 80 percent of the FMV of the shares of the acquiring corporation received in an asset sale must be voting shares for tax-free treatment to be preserved.

Statutory Merger

A statutory merger, known as an 'A' reorganization, occurs when one corporation is merged under state corporate law into a surviving corporation with the shareholders of the merging corporation converting their shares of the merging corporation's stock into shares of stock of the surviving corporation, or the surviving corporation's parent.

The shareholders of the merging corporation may receive assets other than surviving corporation stock in an 'A' reorganization (including cash). However, to the extent that cash and other assets are received by the merging corporation's shareholders, the shareholders will have to recognize gain in the transaction.

When Can It Be Used?

A tax-free sale may be an option when you want to sell your business while avoiding or at least postponing payment of capital gains tax. A tax-free sale will only be possible if your business is organized as a corporation.

Strengths

You Defer Your Capital Gains Tax

Assuming the sale qualifies for tax-free treatment, you and/or your business won't have to pay capital gains tax as a result of the transaction. You will only pay the capital gains tax if you subsequently sell and realize a gain on the shares received from the acquiring corporation.

Public Stock Is a Relatively Liquid Asset

Although a tax-free sale does not provide you with instant cash, you can sell the stock received from the acquiring corporation with relative ease (if it is publicly traded) in the event that you need cash for an emergency.

Caution:  Keep in mind that publicly traded stock is much more liquid than stock in a nonpublic corporation. This may be a crucial point to consider as you plan for a tax-free sale of your business.

Heirs Can Receive Stepped-Up Basis

This can be an important consideration in terms of planning for the future of your children or other heirs. If you hold on to the stock received from the acquiring corporation until your death, you defer your capital gains indefinitely, and your heirs can receive a stepped-up tax basis. If you sold these shares before your death, your tax basis would be based upon your initial investment in your own business. The people who inherit these same shares will have a tax basis equal to the shares' value at the time of your death. If your heirs decide to sell the shares in the future, this stepped-up basis will result in a lower capital gains tax liability.

Caution:  If the value of your estate exceeds the applicable exclusion amount, then holding on to the shares until your death could trigger estate taxes in excess of the capital gains tax that would result from selling the shares during your lifetime. If so, it might be better to sell the stock, pay the capital gains tax, and then transfer the proceeds to your beneficiaries during your lifetime to avoid estate taxes.

Caution:  If an estate of a person who died in 2010 elected out of the federal estate tax, estate assets did not receive a step-up in basis but received a carryover or modified carryover basis instead.

Tradeoffs

A Tax-Free Sale Is a Complicated Transaction

The complexity of structuring a tax-free sale will require that you enlist the aid of an attorney and/or tax advisor.

It Can Be Difficult to Find a Buyer

One obstacle to planning a tax-free sale can be that it is often difficult to find an appropriate acquiring corporation willing to pay you the FMV of your business in the form of voting stock.

There Will Be a Waiting Period Before You Can Sell Stock

While the stock received from the acquiring corporation can be sold fairly easily if the stock is publicly traded, it is still not as liquid as cash. Moreover, federal securities regulations will require you to hold the stock for a period of up to two years before you can resell it, during which time the stock may decrease in value.

There May Be Estate Tax Consequences

If you hold on to the stock until your death, there may be estate tax consequences. Specifically, while holding the stock will allow you to defer your capital gain and provide your beneficiaries with a stepped-up tax basis, keep in mind that upon your death, the stock will become part of your estate and may be subject to federal estate taxes.

Featured Video

Articles you may find interesting:

Loading...

How to Do It

Hire an attorney and/or tax advisor to assist you with setting up the transaction. Establish the FMV of your business and find a corporation willing to exchange shares of their voting stock for the stock or assets of your business. Finally, determine if a tax-free stock sale, a tax-free asset sale, or a statutory merger would be more appropriate in your case.

Tax Considerations

Capital Gains Tax

Assuming the sale qualifies for tax-free treatment, a tax-free sale will enable you and/or your business to defer the capital gains tax triggered by the sale. You will only pay the capital gains tax if you subsequently sell and realize a gain on the shares received from the acquiring corporation or if you receive any consideration from the acquiring corporation other than the acquiring corporation stock in the transaction.

Stepped-Up Basis

Rather than sell the shares during your lifetime, you can hold on to them until your death. Exercising this option will not only further defer your capital gain but may also give your beneficiaries a step-up in their tax basis. If the beneficiaries then sell the shares after your death, their capital gains tax may be significantly less than the capital gains tax you would have paid if you had sold the same shares during your lifetime.

Example(s):  Your initial investment in your business was $50,000. Years later, you structure a tax-free sale of your business and receive shares of voting stock in an acquiring corporation. A year later, you sell the stock received for $100,000. When you subtract your cost basis (the original $50,000 investment) from the $100,000 for which you sold the stock, you get a capital gain of $50,000.

Example(s):  You hold on to the shares received from the acquiring corporation until your death so that your daughter may inherit them. If the shares' value at the time of your death was $120,000, then your daughter's cost basis will also be $120,000. Your daughter needs to sell the shares two months later to raise money for her college tuition. Even if the shares' value rises over the two-month period to $150,000, she can sell the shares for the $150,000 and end up with a capital gain of only $30,000 ($150,000 less her cost basis of $120,000). In effect, the stepped-up basis allows her to realize a taxable gain of $20,000 less than you would have realized even though the shares' value has risen.

Gift and Estate Tax Considerations

Holding on to the shares until your death will cause them to become part of your estate. If the value of the shares plus the other assets in your estate exceeds the applicable exclusion amount, the estate may be subject to federal estate taxes. Depending on the anticipated value of your estate, it may or may not be a good idea to hold on to the shares until your death. It may be a better idea to sell the shares during your lifetime, pay the capital gains tax, and then transfer the proceeds to your beneficiaries before you die to minimize estate taxes.

There may be other estate tax planning issues, particularly for married couples.

What type of retirement savings plan does Lam Research offer to its employees?

Lam Research offers a 401(k) retirement savings plan to its employees.

Does Lam Research provide a company match for contributions to the 401(k) plan?

Yes, Lam Research provides a company match for employee contributions to the 401(k) plan, subject to certain limits.

When can employees at Lam Research start contributing to their 401(k) plan?

Employees at Lam Research can start contributing to their 401(k) plan after completing their initial eligibility period.

What is the maximum contribution limit for the Lam Research 401(k) plan?

The maximum contribution limit for the Lam Research 401(k) plan is in accordance with IRS guidelines, which are updated annually.

Are there investment options available within the Lam Research 401(k) plan?

Yes, the Lam Research 401(k) plan offers a variety of investment options for employees to choose from.

Can employees at Lam Research take loans against their 401(k) savings?

Yes, Lam Research allows employees to take loans against their 401(k) savings, subject to specific terms and conditions.

What happens to my 401(k) balance if I leave Lam Research?

If you leave Lam Research, you can choose to roll over your 401(k) balance to another qualified plan or take a distribution, subject to tax implications.

Is there a vesting schedule for the company match in the Lam Research 401(k) plan?

Yes, there is a vesting schedule for the company match in the Lam Research 401(k) plan, which determines when employees fully own the matched contributions.

How can I access my 401(k) account information at Lam Research?

Employees can access their 401(k) account information through the designated online portal provided by Lam Research.

Does Lam Research offer any educational resources for employees regarding their 401(k) plan?

Yes, Lam Research provides educational resources and workshops to help employees understand their 401(k) plan options and investment strategies.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Lam Research offers a comprehensive retirement plan that includes both a 401(k) and pension plan for its employees. The Lam Research 401(k) Plan is administered by Fidelity Investments, allowing employees to contribute pretax, Roth, and after-tax dollars. The maximum contribution limit for 2024 is $23,000 for those under 50, and $30,500 for those over 50, including catch-up contributions. This 401(k) plan offers flexibility in investment options, allowing employees to diversify their portfolios according to their retirement goals. Additionally, employees can consolidate previous 401(k) accounts and take their retirement savings with them if they leave Lam Research​ (Lam Benefits)​ (Lam Benefits). Lam Research also provides an employee pension plan through a Cash Balance Pension Plan. This plan calculates benefits based on a combination of an employee's earnings and years of service. Employees accrue benefits annually as a percentage of their pay, and the accumulated amount grows with interest credits. Eligibility for the pension plan typically requires at least five years of service, though the specific pension formula may depend on the employee's age and years of service​ (Lam Benefits)​ (Lam Research). The 401(k) Plan and Cash Balance Pension Plan at Lam Research are essential for employees looking to secure their retirement. Employees are encouraged to take advantage of the full range of investment options and matching contributions offered by the company to maximize their retirement savings potential. These plans provide robust support for employees aiming to achieve long-term financial security​ (Lam Benefits)​ (Lam Research).
Restructuring and Layoffs: In January 2023, Lam Research announced significant layoffs, affecting 1,300 employees globally, which amounts to 7% of their workforce. These job cuts were in response to economic challenges and declining semiconductor demand, driven in part by U.S. export controls on China and a global supply glut in memory chips​ (Data Center Dynamics)​ (Enterprise Technology News and Analysis). The layoffs followed a 65% workforce increase during the pandemic, as the company expanded rapidly to meet surging chip demand. Further layoffs were announced later in the year, focusing on realigning the company with market realities. Importance: It is crucial to address these layoffs because they highlight the impact of shifting geopolitical policies, such as U.S.-China trade restrictions, which are reshaping the global semiconductor market. The economic, tax, and political environment continues to influence corporate restructuring decisions, making it vital for stakeholders to monitor these changes.
Lam Research offers employees both stock options and Restricted Stock Units (RSUs) as part of its compensation package. The company's stock options provide employees the right to purchase Lam Research (LRCX) shares at a predetermined price, typically after a vesting period. RSUs, on the other hand, are units that convert into Lam Research shares once vesting conditions are met. These equity-based compensations are offered to eligible employees, generally including top executives and senior management, though they can extend to other staff as a form of long-term incentive. In 2022, 2023, and 2024, Lam Research continued to offer stock options and RSUs, with increased equity-based compensation expenses year-over-year. For example, in 2022, the company reported equity-based compensation expenses of $189.47 million, a significant increase from the previous year. This trend reflects Lam Research's ongoing commitment to providing competitive stock options and RSUs to retain and motivate its workforce​ (Lam Research Investor Relations). These stock options and RSUs are available to Lam Research employees who meet specific service or performance-based criteria, and vesting typically occurs over multiple years. You can refer to Lam Research's official financial reports, such as the Condensed Consolidated Statements of Cash Flows from 2022, for more details on these compensations (page 2 of Lam Research's 2022 investor report)​ (Lam Research Investor Relations).
Lam Research offers a comprehensive health benefits package designed to support employee well-being across multiple dimensions—physical, mental, and financial. The company's healthcare offerings include options such as the Anthem Consumer Directed Health Plan (CDHP) with Health Savings Account (HSA) and Kaiser Permanente Consumer Directed Health Plan (CDHP). These plans provide employees with preventive care at no cost and offer high-deductible structures to allow employees to contribute pretax dollars toward healthcare expenses through Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs)​ (Lam Benefits)​ (Lam Benefits). In addition to traditional health insurance, Lam Research promotes mental wellness through its Employee Assistance Program (EAP), offering free confidential counseling, and its "Live Well" program, which supports year-round physical and emotional well-being​ (Lam Benefits)​ (Lam Research). These benefits are especially significant given the rising healthcare costs in the U.S., with employers anticipating an average 5.4% increase in 2024​ (Lam Benefits). Discussing healthcare benefits in the context of today's economic, investment, and political environment is critical as costs continue to rise and employees seek greater security. For instance, Lam’s approach to healthcare, including telemedicine, virtual physical therapy, and supplemental medical benefits like critical illness insurance, helps employees manage their health more effectively while potentially reducing out-of-pocket expenses​ (Lam Research)​ (Lam Benefits). The introduction of tax-advantaged HSAs and voluntary coverage options further demonstrates the company’s commitment to offering flexible solutions that align with current healthcare challenges and evolving tax laws​ (Lam Benefits). This balance of cost management and comprehensive care reflects Lam's understanding of the modern workforce's needs.
New call-to-action

Additional Articles

Check Out Articles for Lam Research employees

Loading...

For more information you can reach the plan administrator for Lam Research at , ; or by calling them at .

https://www.lambenefits.com/financial/401k-plan https://www.lambenefits.com/enrollment-and-changes/benefits-eligibility https://law-store.wolterskluwer.com/s/product/defined-benefit-answer-book-pension-3-mo-subvitallaw-3r/01t0f00000J3FC4AAN https://www.lambenefits.com/enrollment-and-changes/benefits-eligibility https://www.emparion.com/cash-balance-pension-plan-faq/ https://www.lambenefits.com/ https://www.lamresearch.com/careers/culture-benefits/benefits/ https://www.wealthenhancement.com/s/tools-calculators https://turbotax.intuit.com/tax-tips/retirement/net-unrealized-appreciation-nua-tax-treatment-amp-strategies/c71vBJZ2B https://www.fidelity.com/learning-center/personal-finance/retirement/company-stock https://carlsoncap.com/articles/nua-net-unrealized-appreciation/ https://www.stordahlcap.com/insights/understanding-net-unrealized-appreciation-nua-and-its-tax-benefits https://www.milliman.com/en/insight/interest-rates-pension-plans-implement-liability-driven-investment-strategy https://www.irs.gov/retirement-plans/pension-plan-funding-segment-rates https://www.principal.com/businesses/trends-insights/2023-pension-lump-sums-dropping-new-years-ball https://tracxn.com/d/acquisitions/acquisitions-by-lam-research/__DErv1AGXobP6Vs_JUY3owI7zknPEKzEZpDr92gMvUs0 https://newsroom.lamresearch.com/2022-05-11-Lam-Research-Corporation-Announces-5-Billion-Share-Repurchase-Authorization-and-Declares-Quarterly-Dividend https://www.thelayoff.com/autodesk#google_vignette https://www.nerdwallet.com/article/investing/deferred-compensation https://newsroom.lamresearch.com/2023-04-19-Lam-Research-Corporation-Reports-Financial-Results-for-the-Quarter-Ended-March-26,-2023 https://filecache.investorroom.com/mr5ir_lamresearch2/1303/QMar23%204.19.23.pdf

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Lam Research employees